Stay updated on Lebrikizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab in Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedPublications section now includes a note that items are auto-filled from PubMed, and the Revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedRemoved the government funding/operating status notice from the page.SummaryDifference0.2%

- Check34 days agoChange Detected- Added a new publication to the Publications section: 'Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis' (Clin Exp Dermatol. 2025 Nov 8).SummaryDifference0.0%

- Check49 days agoChange DetectedNo substantive changes detected in the study details between the screenshots; only minor formatting or UI adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference1%

- Check77 days agoChange DetectedAdded a new page revision tag (v3.1.0) and removed several drug-safety topics, indicating a reorganization or narrowing of content rather than new substantive material.SummaryDifference0.1%

Stay in the know with updates to Lebrikizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.